Literature DB >> 26999026

Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity.

Stina L Urban1, Leslie J Berg1, Raymond M Welsh2.   

Abstract

Naïve T cells, unlike memory T cells, exhibit very limited effector function in response to cognate antigen, but exposure to type 1 interferon (IFN) prior to cognate antigen allows for rapid manifestation of effector functions. A full assessment of the functions of these IFN-sensitized otherwise naïve T cells has not been made, nor has their capacity to be effector cells in vivo. We describe here that IFN-sensitized naïve T cells in the absence of cognate antigen adopt a partial activated phenotype distinguished by the upregulation of the surface activation marker CD69, effector-associated transcription factors Eomes and IRF4, and cytotoxicity effector molecule granzyme B. IFN-sensitized naive T cells lysed target cells in vivo and responded to low concentrations and affinities of cognate ligands. We suggest that this rapid and sensitive effector function of IFN-conditioned naïve CD8 T cells may play a role in pathogen control and help ward off superinfections.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-viral, Cytotoxic T lymphocyte; Cytolytic; Effector; Interferon; Naïve CD8 T cell; Virus

Mesh:

Substances:

Year:  2016        PMID: 26999026      PMCID: PMC4860121          DOI: 10.1016/j.virol.2016.03.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

Review 1.  Early events governing memory CD8+ T-cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

2.  Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells.

Authors:  Michael A Brehm; Keith A Daniels; Raymond M Welsh
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

3.  Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation.

Authors:  Julie M Curtsinger; Javier O Valenzuela; Pujya Agarwal; Debra Lins; Matthew F Mescher
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 4.  Signals required for programming effector and memory development by CD8+ T cells.

Authors:  Matthew F Mescher; Julie M Curtsinger; Pujya Agarwal; Kerry A Casey; Michael Gerner; Christopher D Hammerbeck; Flavia Popescu; Zhengguo Xiao
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

5.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.

Authors:  S Oehen; K Brduscha-Riem
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

6.  Autocrine IFN-γ promotes naive CD8 T cell differentiation and synergizes with IFN-α to stimulate strong function.

Authors:  Julie M Curtsinger; Pujya Agarwal; Debra C Lins; Matthew F Mescher
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

7.  Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells.

Authors:  Alice E Denton; Brendan E Russ; Peter C Doherty; Sudha Rao; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

8.  Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

Authors:  Maria Montoya; Giovanna Schiavoni; Fabrizio Mattei; Ion Gresser; Filippo Belardelli; Persephone Borrow; David F Tough
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

9.  Complete but curtailed T-cell response to very low-affinity antigen.

Authors:  Dietmar Zehn; Sarah Y Lee; Michael J Bevan
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

10.  Defining the molecular blueprint that drives CD8(+) T cell differentiation in response to infection.

Authors:  Brendan E Russ; Alice E Denton; Lauren Hatton; Hayley Croom; Matthew R Olson; Stephen J Turner
Journal:  Front Immunol       Date:  2012-12-19       Impact factor: 7.561

View more
  8 in total

1.  Circulation of gut-preactivated naïve CD8+ T cells enhances antitumor immunity in B cell-defective mice.

Authors:  Maryam Akrami; Rosemary Menzies; Kenji Chamoto; Michio Miyajima; Ryuji Suzuki; Hiroyuki Sato; Akiko Nishii; Michio Tomura; Sidonia Fagarasan; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

2.  Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Authors:  Katherine A Waugh; Paula Araya; Ahwan Pandey; Kimberly R Jordan; Keith P Smith; Ross E Granrath; Santosh Khanal; Eric T Butcher; Belinda Enriquez Estrada; Angela L Rachubinski; Jennifer A McWilliams; Ross Minter; Tiana Dimasi; Kelley L Colvin; Dmitry Baturin; Andrew T Pham; Matthew D Galbraith; Kyle W Bartsch; Michael E Yeager; Christopher C Porter; Kelly D Sullivan; Elena W Hsieh; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

3.  Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.

Authors:  Mansi Saxena; Rachel L Sabado; Melissa La Mar; Hiroshi Mohri; Andres M Salazar; Hanqing Dong; Joel Correa Da Rosa; Martin Markowitz; Nina Bhardwaj; Elizabeth Miller
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

Review 4.  The viral innate immune antagonism and an alternative vaccine design for PRRS virus.

Authors:  Hanzhong Ke; Dongwan Yoo
Journal:  Vet Microbiol       Date:  2017-03-18       Impact factor: 3.293

5.  Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.

Authors:  Marilin S Koch; Mykola Zdioruk; Michal O Nowicki; Alec M Griffith; Estuardo Aguilar; Laura K Aguilar; Brian W Guzik; Francesca Barone; Paul P Tak; Ghazaleh Tabatabai; James A Lederer; E Antonio Chiocca; Sean Lawler
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

6.  STAT1 maintains naïve CD8+ T cell quiescence by suppressing the type I IFN-STAT4-mTORC1 signaling axis.

Authors:  Yoon-Chul Kye; Gil-Woo Lee; Sung-Woo Lee; Young-Jun Ju; Hee-Ok Kim; Cheol-Heui Yun; Jae-Ho Cho
Journal:  Sci Adv       Date:  2021-09-01       Impact factor: 14.136

7.  Irradiation Suppresses IFNγ-Mediated PD-L1 and MCL1 Expression in EGFR-Positive Lung Cancer to Augment CD8+ T Cells Cytotoxicity.

Authors:  Chun-I Wang; Yi-Fang Chang; Zong-Lin Sie; Ai-Sheng Ho; Jung-Shan Chang; Cheng-Liang Peng; Chun-Chia Cheng
Journal:  Cells       Date:  2021-09-23       Impact factor: 6.600

8.  Effector CD8 T Cell-Dependent Zika Virus Control in the CNS: A Matter of Time and Numbers.

Authors:  Loulieta Nazerai; Amalie Skak Schøller; Maria Rosaria Bassi; Søren Buus; Anette Stryhn; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.